
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SIRT5 Promotes Cisplatin Resistance in Ovarian Cancer by Suppressing DNA Damage in a ROS-Dependent Manner via Regulation of the Nrf2/HO-1 Pathway
Xiaodan Sun, Shouhan Wang, Junda Gai, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 91
Xiaodan Sun, Shouhan Wang, Junda Gai, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 91
Showing 1-25 of 91 citing articles:
The sirtuin family in health and disease
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 388
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 388
The Role of HO-1 and Its Crosstalk with Oxidative Stress in Cancer Cell Survival
Shih-Kai Chiang, Shuen‐Ei Chen, Ling‐Chu Chang
Cells (2021) Vol. 10, Iss. 9, pp. 2401-2401
Open Access | Times Cited: 131
Shih-Kai Chiang, Shuen‐Ei Chen, Ling‐Chu Chang
Cells (2021) Vol. 10, Iss. 9, pp. 2401-2401
Open Access | Times Cited: 131
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 117
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 117
Role of NRF2 in Ovarian Cancer
Giovanni Tossetta, Sonia Fantone, Eva Montanari, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 663-663
Open Access | Times Cited: 86
Giovanni Tossetta, Sonia Fantone, Eva Montanari, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 663-663
Open Access | Times Cited: 86
The emerging role of ferroptosis in female reproductive disorders
Min Liu, WU Ke-ming, Yeke Wu
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115415-115415
Open Access | Times Cited: 42
Min Liu, WU Ke-ming, Yeke Wu
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115415-115415
Open Access | Times Cited: 42
Research progress on Sirtuins (SIRTs) family modulators
Mingkai Chen, Junfei Tan, Zihan Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116481-116481
Open Access | Times Cited: 18
Mingkai Chen, Junfei Tan, Zihan Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116481-116481
Open Access | Times Cited: 18
Emerging role of NRF2 in ROS-mediated tumor chemoresistance
Danfeng Xue, Xiongming Zhou, Jiaxuan Qiu
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110676-110676
Open Access | Times Cited: 132
Danfeng Xue, Xiongming Zhou, Jiaxuan Qiu
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110676-110676
Open Access | Times Cited: 132
Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2382-2382
Open Access | Times Cited: 95
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2382-2382
Open Access | Times Cited: 95
Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism
Katarína Smolková, Edit Mikó, Tündé Kovàcs, et al.
Antioxidants and Redox Signaling (2020) Vol. 33, Iss. 13, pp. 966-997
Open Access | Times Cited: 72
Katarína Smolková, Edit Mikó, Tündé Kovàcs, et al.
Antioxidants and Redox Signaling (2020) Vol. 33, Iss. 13, pp. 966-997
Open Access | Times Cited: 72
Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators
Ewa Maria Kratz, Katarzyna Sołkiewicz, Adriana Kubis-Kubiak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 630-630
Open Access | Times Cited: 62
Ewa Maria Kratz, Katarzyna Sołkiewicz, Adriana Kubis-Kubiak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 630-630
Open Access | Times Cited: 62
Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy
Lanyu Li, Cheng Qiu, Min Hou, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 58
Lanyu Li, Cheng Qiu, Min Hou, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 58
Sirtuin5 protects colorectal cancer from DNA damage by keeping nucleotide availability
Hao-Lian Wang, Yan Chen, Yun-Qian Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
Hao-Lian Wang, Yan Chen, Yun-Qian Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection
Emanuele Fabbrizi, Francesco Fiorentino, Vincenzo Carafa, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 852-852
Open Access | Times Cited: 35
Emanuele Fabbrizi, Francesco Fiorentino, Vincenzo Carafa, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 852-852
Open Access | Times Cited: 35
Cytoprotective Role of Heme Oxygenase-1 in Cancer Chemoresistance: Focus on Antioxidant, Antiapoptotic, and Pro-Autophagy Properties
Huan Wang, Qi Cheng, Lingjie Bao, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1217-1217
Open Access | Times Cited: 28
Huan Wang, Qi Cheng, Lingjie Bao, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1217-1217
Open Access | Times Cited: 28
SIRT5 Regulates Ferroptosis through the Nrf2/HO-1 Signaling Axis to Participate in Ischemia-Reperfusion Injury in Ischemic Stroke
Jian Li, Wei Gao, Zhaoming Song, et al.
Neurochemical Research (2024) Vol. 49, Iss. 4, pp. 998-1007
Closed Access | Times Cited: 12
Jian Li, Wei Gao, Zhaoming Song, et al.
Neurochemical Research (2024) Vol. 49, Iss. 4, pp. 998-1007
Closed Access | Times Cited: 12
Mitochondrial sirtuins: Energy dynamics and cancer metabolism
Hojun Lee, Haejin Yoon
Molecules and Cells (2024) Vol. 47, Iss. 2, pp. 100029-100029
Open Access | Times Cited: 8
Hojun Lee, Haejin Yoon
Molecules and Cells (2024) Vol. 47, Iss. 2, pp. 100029-100029
Open Access | Times Cited: 8
Targeting Nrf2 may reverse the drug resistance in ovarian cancer
Danjie Li, Xiaoling Hong, Feijie Zhao, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 48
Danjie Li, Xiaoling Hong, Feijie Zhao, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 48
Clinical Significance of Heme Oxygenase 1 in Tumor Progression
Mariapaola Nitti, Caterina Ivaldo, Nicola Traverso, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 789-789
Open Access | Times Cited: 46
Mariapaola Nitti, Caterina Ivaldo, Nicola Traverso, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 789-789
Open Access | Times Cited: 46
Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management
Mohammad Aslam Khan, Kunwar Somesh Vikramdeo, Sarabjeet Kour Sudan, et al.
Seminars in Cancer Biology (2021) Vol. 77, pp. 99-109
Open Access | Times Cited: 41
Mohammad Aslam Khan, Kunwar Somesh Vikramdeo, Sarabjeet Kour Sudan, et al.
Seminars in Cancer Biology (2021) Vol. 77, pp. 99-109
Open Access | Times Cited: 41
Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5
Francesco Fiorentino, Carola Castiello, Antonello Mai, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9580-9606
Open Access | Times Cited: 35
Francesco Fiorentino, Carola Castiello, Antonello Mai, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9580-9606
Open Access | Times Cited: 35
Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia by inhibiting MSH2
Ping Liu, Dan Ma, Ping Wang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Ping Liu, Dan Ma, Ping Wang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme**
Nima Rajabi, Tobias Hansen, Alexander L. Nielsen, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 22
Open Access | Times Cited: 25
Nima Rajabi, Tobias Hansen, Alexander L. Nielsen, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 22
Open Access | Times Cited: 25
SIRT5 desuccinylating IDH2 to alleviate oxidative stress in bovine mammary epithelial cells induced by ammonia
Shikai Gao, Hanlin Yang, Jinru Dong, et al.
International Journal of Biological Macromolecules (2025) Vol. 295, pp. 139619-139619
Closed Access
Shikai Gao, Hanlin Yang, Jinru Dong, et al.
International Journal of Biological Macromolecules (2025) Vol. 295, pp. 139619-139619
Closed Access
Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development
Z. J. Ke, Kaikai Shen, Li Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Z. J. Ke, Kaikai Shen, Li Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Overcoming drug resistance in ovarian cancer through PI3K/AKT signaling inhibitors
Madhunika Agrawal, Satyam Kumar Agrawal, Kanwaljit Chopra
Gene (2025), pp. 149352-149352
Closed Access
Madhunika Agrawal, Satyam Kumar Agrawal, Kanwaljit Chopra
Gene (2025), pp. 149352-149352
Closed Access